Stockreport

BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights [TheStreet.com]

BioAtla, Inc.  (BCAB) 
PDF global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, to [Read more]